Investors

Latest Announcements

Press Release

Provisional Patent Application

Read More
Press Release

Woke and Swinburne University Sign Memorandum of Understanding to Develop WP002 Psilocybin-assisted Psychotherapy Phase IIB trial in Treatment-Resistant Depression

Read More
Press Release

Woke and QIMR Berghofer Sign Letter of Intent for Clinical Trial of WP002 Psilocybin in Prolonged Grief

Read More
Press Release

Woke Highlights Morgan Stanley Report on Psychedelics

Read More

Latest Presentations

Presentation

September 2022 Corporate Presentation

Read More

Latest Media

Media

Potential Therapeutic Benefits of Psychedelics

Read More
Media

Can microdosing psychedelics improve your mental health? Here's what the science says

Read More
Media

Elon Musk has joined the celebrity support for psychedelics

Read More
Media

Woke and UWA enter agreement to identify novel LSD analogues

Read More

ACN: 651 290 729

Address: Suite 301, 10 Bridge St, Sydney NSW 2000 Australia

Email: info@wokeph.com